Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction A Meta-Analysis of Preclinical Studies and Clinical Trials

被引:146
作者
Kanelidis, Anthony J. [1 ]
Premer, Courtney [1 ,2 ]
Lopez, Juan [4 ]
Balkan, Wayne [1 ,3 ]
Hare, Joshua M. [1 ,3 ]
机构
[1] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Coral Gables, FL 33124 USA
[2] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Coral Gables, FL 33124 USA
[3] Univ Miami, Dept Med, Coral Gables, FL 33124 USA
[4] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA
基金
美国国家卫生研究院;
关键词
cell- and tissue-based therapy; heart failure; mesenchymal stem cell transplantation; meta-analysis; myocardial infarction; LEFT-VENTRICULAR FUNCTION; LARGE ANIMAL-MODELS; IMPROVES CARDIAC-FUNCTION; ISCHEMIC CARDIOMYOPATHY; PORCINE MODEL; TISSUE PERFUSION; HEME OXYGENASE-1; TRANSPLANTATION; HEART; INJECTION;
D O I
10.1161/CIRCRESAHA.116.309819
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Accumulating data support a therapeutic role for mesenchymal stem cell (MSC) therapy; however, there is no consensus on the optimal route of delivery. Objective: We tested the hypothesis that the route of MSC delivery influences the reduction in infarct size and improvement in left ventricular ejection fraction (LVEF). Methods and Results: We performed a meta-analysis investigating the effect of MSC therapy in acute myocardial infarction (AMI) and chronic ischemic cardiomyopathy preclinical studies (58 studies; n= 1165 mouse, rat, swine) which revealed a reduction in infarct size and improvement of LVEF in all animal models. Route of delivery was analyzed in AMI swine studies and clinical trials (6 clinical trials; n= 334 patients). In AMI swine studies, transendocardial stem cell injection reduced infarct size (n= 49, 9.4% reduction; 95% confidence interval, -15.9 to -3.0), whereas direct intramyocardial injection, intravenous infusion, and intracoronary infusion indicated no improvement. Similarly, transendocardial stem cell injection improved LVEF (n= 65, 9.1% increase; 95% confidence interval, 3.7 to 14.5), as did direct intramyocardial injection and intravenous infusion, whereas intracoronary infusion demonstrated no improvement. In humans, changes of LVEF paralleled these results, with transendocardial stem cell injection improving LVEF (n= 46, 7.0% increase; 95% confidence interval, 2.7 to 11.3), as did intravenous infusion, but again intracoronary infusion demonstrating no improvement. Conclusions: MSC therapy improves cardiac function in animal models of both AMI and chronic ischemic cardiomyopathy. The route of delivery seems to play a role in modulating the efficacy of MSC therapy in AMI swine studies and clinical trials, suggesting the superiority of transendocardial stem cell injection because of its reduction in infarct size and improvement of LVEF, which has important implications for the design of future studies.
引用
收藏
页码:1139 / +
页数:30
相关论文
共 84 条
[1]   Preconditioning Promotes Survival and Angiomyogenic Potential of Mesenchymal Stem Cells in the Infarcted Heart via NF-κB Signaling [J].
Afzal, Muhammad R. ;
Haider, Husnain Kh. ;
Idris, Niagara Muhammad ;
Jiang, Shujia ;
Ahmed, Rafeeq P. H. ;
Ashraf, Muhammad .
ANTIOXIDANTS & REDOX SIGNALING, 2010, 12 (06) :693-702
[2]  
Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
[3]   Mesenchymal Stem Cells Provide Better Results Than Hematopoietic Precursors for the Treatment of Myocardial Infarction [J].
Arminan, Ana ;
Gandia, Carolina ;
Manuel Garcia-Verdugo, J. ;
Lledo, Elisa ;
Trigueros, Cesar ;
Ruiz-Sauri, Amparo ;
Dolores Minana, Maria ;
Solves, Pilar ;
Paya, Rafael ;
Anastasio Montero, J. ;
Sepulveda, Pilar .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (20) :2244-2253
[4]   Stem cell paracrine actions and tissue regeneration [J].
Baraniak, Priya R. ;
McDevitt, Todd C. .
REGENERATIVE MEDICINE, 2010, 5 (01) :121-143
[5]   Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart [J].
Buccini, Stephanie ;
Haider, Khawaja Husnain ;
Ahmed, Rafeeq P. H. ;
Jiang, Shujia ;
Ashraf, Muhammad .
BASIC RESEARCH IN CARDIOLOGY, 2012, 107 (06)
[6]   Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction [J].
Chen, SL ;
Fang, W ;
Ye, F ;
Liu, YH ;
Qian, J ;
Shan, S ;
Zhang, J ;
Zhao, RCH ;
Liao, LM ;
Lin, S ;
Sun, JP .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (01) :92-95
[7]   Timing of transplantation of autologous bone marrow derived mesenchymal stem cells for treating myocardial infarction [J].
Chen YiHuan ;
Teng XiaoMei ;
Chen WeiQian ;
Yang JunJie ;
Yang ZiYing ;
Yu YunSheng ;
Shen ZhenYa .
SCIENCE CHINA-LIFE SCIENCES, 2014, 57 (02) :195-200
[8]   Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats [J].
Dai, Wangde ;
Hale, Sharon L. ;
Kloner, Robert A. .
REGENERATIVE MEDICINE, 2007, 2 (01) :63-68
[9]   Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium - Short- and long-term effects [J].
Dai, WD ;
Hale, SL ;
Martin, BJ ;
Kuang, JQ ;
Dow, JS ;
Wold, LE ;
Kloner, RA .
CIRCULATION, 2005, 112 (02) :214-223
[10]   Differential Effects of Progenitor Cell Populations on Left Ventricular Remodeling and Myocardial Neovascularization After Myocardial Infarction [J].
Dubois, Christophe ;
Liu, Xiaoshun ;
Claus, Piet ;
Marsboom, Glenn ;
Pokreisz, Peter ;
Vandenwijngaert, Sara ;
Depelteau, Helene ;
Streb, Witold ;
Chaothawee, Lertlak ;
Maes, Frederik ;
Gheysens, Olivier ;
Debyser, Zeger ;
Gillijns, Hilde ;
Pellens, Marijke ;
Vandendriessche, Thierry ;
Chuah, Marinee ;
Collen, Desire ;
Verbeken, Erik ;
Belmans, Ann ;
Van de Werf, Frans ;
Bogaert, Jan ;
Janssens, Stefan .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (20) :2232-2243